Rabeprazole Sodium & Itopride Prolonged Release Capsules – Rabaval IT Capsules

Rabaval IT Capsules
Composition:- Rabeprazole Sodium 20 mg + Itopride 150 mg sustained release

Rabaval IT Capsules – Rabeprazole Sodium & Itopride Prolonged Release Capsules combine Rabeprazole, a proton pump inhibitor (PPI), and Itopride, a prokinetic agent. Rabeprazole effectively suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme, aiding in the treatment of GERD, peptic ulcers, and oesophageal damage caused by excess stomach acid. Itopride enhances gastrointestinal motility through dual mechanisms: D2 receptor antagonism and acetylcholinesterase inhibition, which help accelerate gastric emptying and relieve symptoms of dyspepsia and bloating. This combination is highly effective in acid reflux, chronic gastritis, and functional dyspepsia.
Marketed by: Wonne International Pvt. Ltd.

Key Points of Rabeprazole Sodium & Itopride Prolonged Release Capsules – Rabaval IT Capsules

• Dual-Action Relief – Combination reduces high stomach acid while improving gastric motility for better digestion.
• Promotes Gastric Healing – Aids in the recovery of peptic and gastric ulcers by reducing acid production and helps in GERD management, relieves acid reflux, heartburn, and regurgitation.
• Alleviates Nausea & Vomiting – Itopride’s prokinetic action helps control nausea and discomfort associated with acid reflux and slows gastric emptying.
• Sustained release – Sustained release form of itopride ensures full-day relief of nausea and vomiting, and improves patient convenience.

• General Physician
• Gastroenterologist
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.